Literature DB >> 21134987

Nasopharyngeal extranodal NK/T-cell lymphoma, nasal type: retrospective study of 18 consecutive cases in Guangzhou, China.

Yu-Hua Huang1, Qiu-Liang Wu, Yong-Sheng Zong, Yan-Fen Feng, Jing-Hui Hou.   

Abstract

OBJECTIVE: The aim of this study was to investigate the frequency and clinicopathologic features of nasopharyngeal extranodal NK/T-cell lymphoma, nasal type (NKTCL), as well as DNA sequence variation of Epstein-Barr virus (EBV) in neoplastic cells harboring in NKTCLs from Guangzhou district.
MATERIALS AND METHODS: The clinical data of 18 unselected consecutive nasopharyngeal NKTCLs in one institution were reviewed retrospectively. Immunohistochemical staining and EBV-encoded RNAs (EBERs) in situ hybridization were applied. DNA extraction, polymerase chain reaction (PCR), nested PCR, and sequencing for analyzing the C-terminal and N-terminal regions of LMP1 gene as well as BamHI F fragment of EBV were applied in 16 available samples.
RESULTS: NKTCLs accounted for 69.2% (18/26) of nasopharyngeal T- and NK-cell lineage non-Hodgkin lymphomas. In all, 10 out of 18 patients (55.56%) had cervical lymph node(s) involvement. The serum anti-EBV antibody level was elevated (VCA-IgA titer ≥1:40) in 6 of 12 available patients. Two major immunophenotypic subtypes, namely, TIA-1+/EBERs+/CD56+ (10 cases) and TIA-1+/EBERs+/CD56- (8 cases) could be recognized. Genotyping analysis revealed that 10 out of 13 cases (76.9%) of NKTCL were harbored with del-LMP1 [del-LMP1 (Gly335) variant 7 cases, del-LMP1 (Asp335) variant 3 cases]. XhoI-loss was shown in 8/11 cases (72.73%). BamHI "f" variant of Bam F fragment was shown only in 4/14 cases (28.57%).The most common combination was del-LMP1 (Gly335)/ XhoI-loss/F (6/9, 66.7%).
CONCLUSIONS: The majority of nasopharyngeal T- and NK-cell lymphomas are NKTCL in Guangzhou district. The patients often have involvement of cervical lymph node(s) and an elevated level of serum anti-EBV antibodies. The CD56 expression rate seems lower than that found in sinonasal NKTCL. The most common EBV variant harboring in nasopharyngeal NKTCL seems somewhat different from that harboring in nasopharyngeal carcinoma in Guangzhou.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134987     DOI: 10.1177/1066896910388806

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  6 in total

1.  The association between circulating tumor cells and Epstein-Barr virus activation in patients with nasopharyngeal carcinoma.

Authors:  Caiyun He; Xinjun Huang; Xuan Su; Tao Tang; Xiao Zhang; Jiangjun Ma; Xiang Guo; Xing Lv
Journal:  Cancer Biol Ther       Date:  2017-01-25       Impact factor: 4.742

2.  Lack of epidermal growth factor receptor gene mutations in exons 19 and 21 in primary lymphoepithelioma-like carcinoma of the lung.

Authors:  Qianwen Liu; Guowei Ma; Haoxian Yang; Jing Wen; Mei Li; Hong Yang; Kongjia Luo; Yi Hu; Jianhua Fu
Journal:  Thorac Cancer       Date:  2014-01-02       Impact factor: 3.500

3.  Detection of rearrangement of anaplastic lymphoma kinase (ALK) and mutation of epidermal growth factor receptor (EGFR) in primary pulmonary lymphoepithelioma-like carcinoma.

Authors:  Liang Wang; Yongbin Lin; Qingqing Cai; Hao Long; Yu Zhang; Tiehua Rong; Guowei Ma; Ying Liang
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

4.  Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.

Authors:  Yuhua Huang; Huilan Rao; Shumei Yan; Fang Wang; Qinian Wu; Yanfen Feng; Yujing Zhang
Journal:  Ann Hematol       Date:  2017-05-27       Impact factor: 3.673

5.  Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma.

Authors:  Zhiwei Liu; Yomani D Sarathkumara; John K C Chan; Yok-Lam Kwong; Tai Hing Lam; Dennis Kai Ming Ip; Brian C-H Chiu; Jun Xu; Yu-Chieh Su; Carla Proietti; Martha M Cooper; Kelly J Yu; Bryan Bassig; Raymond Liang; Wei Hu; Bu-Tian Ji; Anna E Coghill; Ruth M Pfeiffer; Allan Hildesheim; Nathaniel Rothman; Denise L Doolan; Qing Lan
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.996

Review 6.  EBV and the Pathogenesis of NK/T Cell Lymphoma.

Authors:  Ivonne A Montes-Mojarro; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Cancers (Basel)       Date:  2021-03-19       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.